Detalles de la búsqueda
1.
Olaparib for childhood tumors harboring defects in DNA damage repair genes: arm H of the NCI-COG Pediatric MATCH trial.
Oncologist
; 2024 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38815151
2.
Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G.
Oncologist
; 2024 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38873934
3.
Recent advances in the treatment of childhood cancers.
Curr Opin Pediatr
; 36(1): 57-63, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37966889
4.
Neoadjuvant pazopanib in nonrhabdomyosarcoma soft tissue sarcomas (ARST1321): A report of major wound complications from the Children's Oncology Group and NRG Oncology.
J Surg Oncol
; 127(5): 871-881, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36779385
5.
Local treatment of rhabdomyosarcoma of the female genital tract: Expert consensus from the Children's Oncology Group, the European Soft-Tissue Sarcoma Group, and the Cooperative Weichteilsarkom Studiengruppe.
Pediatr Blood Cancer
; 70(5): e28601, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32762004
6.
Surgical management of extremity rhabdomyosarcoma: A consensus opinion from the Children's Oncology Group, the European Pediatric Soft-Tissue Sarcoma Study Group, and the Cooperative Weichteilsarkom Studiengruppe.
Pediatr Blood Cancer
; 70(3): e28608, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32776456
7.
TP53 germline pathogenic variant frequency in anaplastic rhabdomyosarcoma: A Children's Oncology Group report.
Pediatr Blood Cancer
; : e30413, 2023 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37194615
8.
A pilot study evaluating the use of sirolimus in children and young adults with desmoid-type fibromatosis.
Pediatr Blood Cancer
; : e30466, 2023 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37283290
9.
An updated assessment of 43,110 patients enrolled in the Childhood Cancer Research Network: A Children's Oncology Group report.
Cancer
; 128(14): 2760-2767, 2022 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35482017
10.
Rising drug cost impacts on cost-effectiveness of 2 chemotherapy regimens for intermediate-risk rhabdomyosarcoma: A report from the Children's Oncology Group.
Cancer
; 128(2): 317-325, 2022 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34623638
11.
Patients with completely resected nongenitourinary low-risk embryonal rhabdomyosarcoma are candidates for reduced duration low-intensity chemotherapy.
Cancer
; 128(23): 4150-4156, 2022 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36250420
12.
An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children's Oncology Group clinical trials.
Pediatr Blood Cancer
; 69(4): e29511, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35129294
13.
Clinical group and modified TNM stage for rhabdomyosarcoma: A review from the Children's Oncology Group.
Pediatr Blood Cancer
; 69(6): e29644, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35253352
14.
Creating a data commons: The INternational Soft Tissue SaRcoma ConsorTium (INSTRuCT).
Pediatr Blood Cancer
; 69(11): e29924, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35969120
15.
Is Detection of Relapse by Surveillance Imaging Associated With Longer Survival in Patients With Rhabdomyosarcoma?
J Pediatr Hematol Oncol
; 44(6): 305-312, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35137727
16.
Survival outcomes of patients with localized FOXO1 fusion-positive rhabdomyosarcoma treated on recent clinical trials: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Cancer
; 127(6): 946-956, 2021 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33216382
17.
Benefit of delayed primary excision in rhabdomyosarcoma: A report from the Children's Oncology Group.
Cancer
; 127(2): 275-283, 2021 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33079399
18.
SARC025 arms 1 and 2: A phase 1 study of the poly(ADP-ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcoma.
Cancer
; 127(8): 1301-1310, 2021 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33289920
19.
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.
N Engl J Med
; 378(8): 731-739, 2018 02 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-29466156
20.
Pharmacogenomic associations of cyclophosphamide pharmacokinetic candidate genes with event-free survival in intermediate-risk rhabdomyosarcoma: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 68(11): e29203, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34245211